D. Ohlendorf

发表

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

P Reichardt, R Gürtler, D. Huhn, 1996, Cancer research.

Surfactant systems for drag reduction: Physico-chemical properties and rheological behaviour

H. Hoffmann, D. Ohlendorf, Heinz Hoffmann, 1986 .

Oral isobutyramide reduces transfusion requirements in some patients with homozygous β-thalassemia

G. Henze, A. Kage, A. Kulozik, 2000 .

Epidoxorubicin in 14 Patients with Advanced Solid Tumors1

D. Huhn, P. Hohenberger, H. Riess, 2011 .

Screening methods using sulfamethazine for determining acetylator phenotype

M. Gibaldi, K. Stoeckel, A. Mclean, 1979, Clinical pharmacology and therapeutics.

The phenolic oxidation of a β-methylchalcone

R. Ward, D. Ohlendorf, A. Pelter, 1979 .

Heat capacities between 1.5 and 16 K and superconductivity of V/H and Nb/H alloys☆

D. Ohlendorf, E. Wicke, 1979 .

Configurational entropy and structure of β-LaNi5 hydride

H. Flotow, D. Ohlendorf, W. Wallace, 1981 .

Heat capacities and thermodynamic functions of LaNi5, LaNi5H0.36 and LaNi5H6.39 from 5 to 300 K☆

H. Flotow, D. Ohlendorf, 1980 .

Experimental heat capacities of LaNi5, α‐LaNi5H0.36, and β‐LaNi5H6.39 from 5 to 300 °K. Thermodynamic properties of the LaNi5–H2 system

H. Flotow, D. Ohlendorf, 1980 .

IRREVERSIBLE CHANGE IN MAGNETIC AND LOW TEMPERATURE CALORIMETRIC PROPERTIES OF TiFe BY HYDROGENATION

R. Hempelmann, D. Ohlendorf, E. Wicke, 1978 .

EXPERIMENTAL HEAT CAPACITIES OF LANTHANUM-NICKEL (LANI5), α-LANTHANUM-NICKEL-HYDROGEN (LANI5H0.36), AND β-LANTHANUM-NICKEL-HYDROGEN (LANI5H6.39) FROM 5 TO 300°K. THERMODYNAMIC PROPERTIES OF THE LANTHANUM-NICKEL (LANI5)-HYDROGEN SYSTEM

H. Flotow, D. Ohlendorf, 1980 .

Three Classes of New Chiral Dopants: Synthesis and Physical Qualification as Dopants for Practical FLC-Mixtures

D. Ohlendorf, M. Murakami, H. Dübal, 1988 .

Dependence of spontaneous polarization, rotational viscosity and helical pitch of smectic c* compounds on the enantiomeric excess

D. Ohlendorf, H. Dübal, C. Escher, 1988 .

The SSFLC switching behaviour in view of chevron layer geometry and ionic charges

T. Harada, D. Ohlendorf, Takamasa Harada, 1991 .

New practical broad range FLC-mixtures for display application

D. Ohlendorf, H. Dübal, C. Escher, 1988 .

The behaviour of drag-reducing cationic surfactant solutions

D. Ohlendorf, D. Ohlendorf, H. W. Bewersdorff, 1988 .

Oral isobutyramide reduces transfusion requirements in some patients with homozygousb-thalassemia

G. Henze, A. Kage, A. Kulozik, 2000 .

Low temperature specific heat and magnetic properties of V/FE and V/FE/H alloys

D. Ohlendorf, E. Wicke, A. Obermann, 1979 .

Dithranol in an Emulsifying Oil Base (Bio-Wash-Oil) for the Treatment of Psoriasis of the Scalp

B. Henz, D. Ohlendorf, N. Haas, 2004, Skin Pharmacology and Physiology.